Category WHO

WHO Board Debates Framework On Engagement With Non-State Actors

The World Health Organization routinely works with a number of outside actors, such as non-governmental groups, philanthropic organisations, industry and academics. Member states have been trying to establish a framework to regulate such engagement and are still working to produce a consensus document. This week they are trying to extend the mandate of an intergovernmental meeting in the hope that an ultimate meeting in April can solve remaining issues.

WHO To Study Effect Of Nagoya Protocol On Sharing Of Genetic Materials

The implementation of a protocol ensuring access to genetic resources and the fair and equitable benefit-sharing of commercial benefits might affect the sharing of pathogens samples between countries, said the United Kingdom and the Netherlands, who asked the World Health Organization to study possible implications of the protocol’s implementation.

Record Attendance, Agenda Open WHO Board Meeting; Global Vision On Infectious Disease

Response to diseases outbreaks must be changed at the World Health Organization, Director General Margaret Chan told the opening of the Executive Board meeting today. She also called for universal health coverage and the implementation of the international health regulation, and for action in the fight against antimicrobial resistance.

WHO Board To Address Reform Progress, R&D Financing, Lobbyists/ Foundations

Next week, the World Health Organization Executive Board will hold its biannual meeting. On the agenda are key subjects such as the WHO reform process, sharing of influenza viruses for R&D, and a controversial framework for the WHO’s engagement with actors such as non-governmental organisations, private entities, and foundations. Also on the agenda is the effort to address the growing microbial resistance to antibiotics, and finding a way to finance research and development for diseases affecting primarily developing countries.

Medicines Patent Pool Announces Sub-Licensing Agreements For Hepatitis C Generics

By Jahan ‘Harry’ Taubman-Rezakhanlou for Intellectual Property Watch The Medicines Patent Pool today announced its first round of sub-licensing agreements with four generic manufacturers for the production and sale of a generic line of Bristol-Myers Squibb’s daclatasvir to 112 lower-to…

TPP, India Most-Read IP-Watch Stories Of 2015

The most-read stories of 2015 on the Intellectual Property Watch website fairly reflected the trends of the year, with the Trans-Pacific Partnership (TPP) agreement, India’s evolving intellectual property rights policies, European Patent Office patents on conventional vegetables, biologics, 3D printing, and some pop culture issues leading the way.

In the coming weeks, IP-Watch will review in-depth what’s in store for 2016, already underway. But for now, let’s take a look at last year’s highlights.

University Students Energise Global Campaign For Medical R&D Agreement

The force of hundreds of students worldwide has gathered behind an international effort urging governments to promote research and development in a way that does not result in high-priced medicines. The initiative led by Universities Allied for Essential Medicines (UAEM) seeks to address the longstanding gap in affordable medicines and puts the focus on the World Health Organization, whose members are currently working on this issue.

UN Launches High-Level Panel On Access To Medicines

A United Nations high-level panel of experts has set a process in motion to find solutions to increase access to medicines. Following its first meeting last week, the panel will call for proposals to recommend solutions that can promote innovation, but preserve human rights and public health interests.

WHO Report Examines Health Achievements, Future Challenges For Implementation Of SDGs

From the United Nations Millennium Development Goals to the Sustainable Development Goals, what are the main achievements in health and what are the main challenges for the next 15 years? That is the question the World Health Organization sought to answer in a new publication issued yesterday.